These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 7966873)

  • 21. [Heart failure and arrhythmia: modalities and indications of prevention of thromboembolism].
    Prati PL; Piazza V
    Cardiologia; 1994 Dec; 39(12 Suppl 1):353-6. PubMed ID: 7634296
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Anticoagulation in dilated cardiomyopathy.
    Koniaris LS; Goldhaber SZ
    J Am Coll Cardiol; 1998 Mar; 31(4):745-8. PubMed ID: 9525541
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Thromboembolism and antithrombotic therapy in congestive heart failure.
    Dunkman WB
    J Cardiovasc Risk; 1995 Apr; 2(2):107-17. PubMed ID: 7606647
    [TBL] [Abstract][Full Text] [Related]  

  • 24. What do we know about anticoagulation in patients with heart failure?
    Ahnert AM; Freudenberger RS
    Curr Opin Cardiol; 2008 May; 23(3):228-32. PubMed ID: 18382211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anticoagulation and heart failure.
    Graham SP
    Curr Cardiol Rep; 2001 Jan; 3(1):72-7. PubMed ID: 11139802
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Anticoagulant therapy in left ventricular non-compaction: when, how and why].
    Costantino J; Maria Ajmone F; Maggio E; Ballatore F; Manguso G; Ciaramella P; Galea N; Alfarano M; Severino P; Lavalle C; Vizza CD; Chimenti C
    G Ital Cardiol (Rome); 2023 Nov; 24(11):866-871. PubMed ID: 37901977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A rationale for the use of anticoagulation in heart failure management.
    Pulerwitz T; Rabbani LE; Pinney SP
    J Thromb Thrombolysis; 2004 Apr; 17(2):87-93. PubMed ID: 15306743
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Management of heart failure. I. Pharmacologic treatment.
    Baker DW; Konstam MA; Bottorff M; Pitt B
    JAMA; 1994 Nov; 272(17):1361-6. PubMed ID: 7933398
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of heart failure. III. The role of revascularization in the treatment of patients with moderate or severe left ventricular systolic dysfunction.
    Baker DW; Jones R; Hodges J; Massie BM; Konstam MA; Rose EA
    JAMA; 1994 Nov; 272(19):1528-34. PubMed ID: 7966846
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Anticoagulation in heart failure without atrial fibrillation: gaps and dilemmas in current clinical practice.
    Siliste RN; Antohi EL; Pepoyan S; Nakou E; Vardas P
    Eur J Heart Fail; 2018 Jun; 20(6):978-988. PubMed ID: 29504188
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Anticoagulation in Patients with Heart Failure and Sinus Rhythm.
    Li X; Yang J; Xu D
    Int Heart J; 2020 Nov; 61(6):1204-1211. PubMed ID: 33191346
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Anticoagulation therapy in patients with heart failure due to systolic dysfunction and sinus rhythm: analysis of REDINSCOR registry.
    Avellana P; Segovia J; Ferrero A; Vázquez R; Brugada J; Borrás X; Alonso-Pulpón L; Cinca J
    Rev Esp Cardiol (Engl Ed); 2012 Aug; 65(8):705-12. PubMed ID: 22464104
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Does heart failure confer a hypercoagulable state? Virchow's triad revisited.
    Lip GY; Gibbs CR
    J Am Coll Cardiol; 1999 Apr; 33(5):1424-6. PubMed ID: 10193748
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Oral anticoagulation with warfarin for patients with left ventricular systolic dysfunction.
    Snowden S; Silus L
    Cardiol Rev; 2011; 19(1):36-40. PubMed ID: 21135601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Relationship between degree of left ventricular dysfunction, symptom status, and risk of embolic events in patients with atrial fibrillation and heart failure.
    Sandhu RK; Hohnloser SH; Pfeffer MA; Yuan F; Hart RG; Yusuf S; Connolly SJ; McAlister FA; Healey JS
    Stroke; 2015 Mar; 46(3):667-72. PubMed ID: 25628308
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aspirin, oral anticoagulants, and heart failure].
    Gibelin P
    Arch Mal Coeur Vaiss; 1998 Nov; 91(11):1377-81. PubMed ID: 9864607
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Ejection fraction and risk of thromboembolic events in patients with systolic dysfunction and sinus rhythm: evidence for gender differences in the studies of left ventricular dysfunction trials.
    Dries DL; Rosenberg YD; Waclawiw MA; Domanski MJ
    J Am Coll Cardiol; 1997 Apr; 29(5):1074-80. PubMed ID: 9120162
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Maze procedure in patients with left ventricular dysfunction.
    Kim JB; Chong BK; Jung SH; Choo SJ; Chung CH; Lee JW
    Int J Cardiol; 2014 Jan; 170(3):331-7. PubMed ID: 24268862
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Anticoagulation for heart failure in sinus rhythm: a Cochrane systematic review.
    Lip GY; Gibbs CR
    QJM; 2002 Jul; 95(7):451-9. PubMed ID: 12096150
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Occurrence of thromboembolic complications in patients with dilated cardiomyopathy. Retrospective-prospective study].
    Polić S; Biocić M; Lukin A; Rumboldt Z; Bagatin J; Pivac N; Rakić D; Naranca M
    Lijec Vjesn; 1997; 119(5-6):142-6. PubMed ID: 9379820
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.